{
    "2021-09-01": [
        [
            {
                "time": "2023-08-31",
                "original_text": "泰格医药(03347)8月31日斥3亿元首次回购223.89万股A股股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "回购",
                        "股份",
                        "3亿元",
                        "223.89万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-01",
                "original_text": "泰格医药：8月31日、9月1日合计耗资3.12亿元回购233.25万股A股股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "回购",
                        "股份",
                        "3.12亿元",
                        "233.25万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-01",
                "original_text": "泰格医药(300347.SZ)：8月31日首次回购223.89万股A股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "首次回购",
                        "223.89万股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-01",
                "original_text": "天风证券维持泰格医药买入评级：业绩强劲增长，在手订单持续放量",
                "features": {
                    "keywords": [
                        "天风证券",
                        "泰格医药",
                        "买入评级",
                        "业绩增长",
                        "订单放量"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-01",
                "original_text": "医药生物行业周报：医美行业强化监管 安徽省IVD集采结果公布",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医美行业",
                        "强化监管",
                        "安徽省",
                        "IVD集采"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-09-01",
                "original_text": "医药与健康护理行业月报：智飞生物新冠疫苗III期数据优异 对变异株仍然有效",
                "features": {
                    "keywords": [
                        "医药",
                        "智飞生物",
                        "新冠疫苗",
                        "III期数据",
                        "变异株"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}